In a meta-analysis, Zheng et al. found PD-L1 immunoreactivity to be a negative prognostic factor in soft tissue sarcomas [8], while other studies found no significant impact on survival in retroperitoneal liposarcoma [30] and chondrosarcoma [12,14]. This evidence concerns the gene CD274 and soft tissue sarcoma.